Flu Virus Entry Mechanism Discovered
Analysis based on 7 articles · First reported Jun 02, 2026 · Last updated Jun 03, 2026
This discovery could lead to the development of new antiviral medications that specifically target different flu strains like Influenza A virus subtype H3N2, potentially creating new revenue streams for pharmaceutical and biotechnology companies. It may also reduce the economic burden of seasonal influenza by improving prevention and treatment outcomes.
Scientists led by Emily Bruce>>> at the University of Vermont's Larner College of Medicine made an accidental breakthrough in understanding how influenza viruses infect cells. They discovered that different flu strains, specifically Influenza A virus subtype H1N1>>> and Influenza A virus subtype H3N2, use distinct strategies to enter human lung cells. Crucially, they found that Influenza A virus subtype H3N2 viruses depend on a specific human protein called Rab11B>>> for entry, while Influenza A virus subtype H1N1>>> viruses do not. Depleting Rab11B>>> prevented Influenza A virus subtype H3N2 from entering cells. This finding challenges previous assumptions that all flu viruses enter cells in the same way and opens new avenues for developing targeted antiviral medications to prevent influenza infections. The study was published in the Journal of Virology>>>.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard